576
Participants
Start Date
January 31, 1993
Primary Completion Date
December 31, 1998
Study Completion Date
December 31, 1998
ATRA
early introduction of ATRA
ATRA and or Chemo as maintenance
patients were randomized both to receive or not receive intermittent ATRA (45 mg/m2/d, 15 days every 3 months) and to receive or not receive continuous CT with 6 mercaptopurine (90 mg/m2/d, orally) and methotrexate (15 mg/m2/wk, orally), according to a 2-by-2 factorial design stratified on the initial induction treatment group
DRC lille, France
UNKNOWN
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
OTHER